As of Sep 04
| +0.14 / +2.25%|
The 5 analysts offering 12-month price forecasts for BioDelivery Sciences International Inc have a median target of 17.00, with a high estimate of 21.00 and a low estimate of 14.00. The median estimate represents a +166.88% increase from the last price of 6.37.
The current consensus among 5 polled investment analysts is to Buy stock in BioDelivery Sciences International Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.